Pharma/Biotech News
Subscribe to Pharma/Biotech News
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Non-FDA Approved Hormone Therapies on the Rise

March 25, 2015 9:36 am | by Cynthia Fox, Science Writer | Articles | Comments

Use of potentially risky, non-FDA approved hormone therapies may soon be as common as use of FDA-approved hormone therapies, according to a study by University of Virginia gynecology researcher JoAnn Pinkerton. Read more..

Blueprint Medicine Files for IPO

March 25, 2015 9:30 am | by Ryan Bushey, Associate Editor | Articles | Comments

The biotech firm is making a big bet on the success of its precision therapies. Read more...

Takeda Licenses Rights to Use Immunogen's Technology to Develop Anticancer Therapies

March 25, 2015 8:44 am | News | Comments

Takeda will use the technology to develop and commercialize targeted anticancer therapeutics to up to two undisclosed  targets. Read more...


GSK Seeks Early Drug Discovery Partnerships with Academics in Europe, Canada, and U.S.

March 25, 2015 8:37 am | News | Comments

This program designed to accelerate the translation of early-stage research into game-changing new medicines. Read more...

Pfizer, Lilly To Resume Phase 3 Chronic Pain Program For Tanezumab

March 24, 2015 12:37 pm | News | Comments

Pfizer Inc. and Eli Lilly and Company announced that they are preparing to resume the Phase 3 clinical program for tanezumab. Read more...

Bristol-Myers Acquires Novo License for Autoimmune Diseases Research Program

March 24, 2015 12:33 pm | News | Comments

Bristol-Myers Squibb Company announced the company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research program focused on modulating the innate immune system as a therapy for autoimmune diseases. Read more...

Gilead Issues Safety Alert over Hepatitis C, Heart Drug Combination

March 24, 2015 12:03 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Taking these medications together is ill-advised.

Cipher Pharmaceuticals Acquires Canadian Rights to Novel Psoriasis, Rheumatoid Arthritis Treatment

March 24, 2015 8:54 am | News | Comments

Approximately 500,000 in Canada people receive treatment for psoriasis. Read more...


Neovacs Launches American Subsidiary in Boston

March 24, 2015 8:36 am | News | Comments

Neovacs will be located in Boston within the French Tech Hub. Read more...

Blood Test for Patients on Acne Medication Deemed Unnecessary

March 23, 2015 10:58 am | by Brigham and Women's Hospital | News | Comments

A new study by researchers at Brigham and Women's Hospital (BWH) has found that for young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care expense. Read more...

Cloud Pharmaceuticals, UF Collaborate on Design of Novel Cancer Inhibitors

March 23, 2015 9:59 am | News | Comments

Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, and the University of Florida Department of Medicine have announced an academic collaboration that will help rapidly design and develop novel drugs to inhibit the reproduction of cancer cells. Read more...

Google Teams With MIT, Harvard for Genetics Research Project

March 23, 2015 9:57 am | by Ryan Bushey, Associate Editor | Articles | Comments

The goal of this partnership is to find treatments for aging related diseases. Read more...

Novartis' Cosentyx Shows Sustained Effect and Favorable Safety Profile

March 23, 2015 8:35 am | News | Comments

Novartis announced new two-year results demonstrating strong and sustained efficacy with Cosentyx. Read more...


Biogen: Positive Phase 1 Results for Alzheimer's Drug

March 23, 2015 8:26 am | News | Comments

Treatment with the drug produced a dose and time dependent reduction of amyloid plaque in the brain. Read more...

US Anti-Drugs Work in Colombia Uses Cancer-Linked Herbicide

March 23, 2015 8:24 am | by Joshua Goodman, Associated Press | News | Comments

New labeling on the world's most popular weed killer as a likely cause of cancer is raising more questions for an aerial spraying program in Colombia that underpins U.S.-financed efforts to wipe out cocaine crops. Read more...

FDA Panel Backs GSK Inhaler for Adults, Not Adolescents

March 20, 2015 9:47 am | by Matthew Perrone, AP Health Writer | News | Comments

Government health advisers say a once-a-day respiratory inhaler from GlaxoSmithKline appears safe and effective for adults with asthma, but not for adolescents. Read more...

Sanofi Announces Top-Line Results for Study of Lyxumia

March 19, 2015 4:32 pm | News | Comments

Full results will be presented at the American Diabetes Association 75th Scientific Sessions in Boston. Read more...

AstraZeneca, Daiichi Sankyo to Jointly Commercialize Movantik in U.S.

March 19, 2015 4:28 pm | News | Comments

Movantik is a first-in-class once-daily oral peripherally-acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation. Read more...

AbbVie, C2N Enter Into License Agreement For Alzheimer's Therapy

March 19, 2015 4:17 pm | News | Comments

​AbbVie announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders. Read more....

Provisions for Hepatitis C Drugs Overseas Causes Controversy

March 19, 2015 2:22 pm | by Ryan Bushey, Associate Editor | Articles | Comments

A famous medical nonprofit is concerned about how these drugs will be distributed overseas. Read more...

Why People with Diabetes Can't Buy Generic Insulin

March 19, 2015 1:20 pm | by Johns Hopkins University | News | Comments

A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin under patent from 1923 to 2014. Read more..

AbbVie Seeks $30M Expansion of Plant in Puerto Rico

March 19, 2015 9:30 am | by The Associated Press | News | Comments

Government officials say in a statement issued Wednesday that the Chicago-based company will expand its facilities in the north coastal town of Barceloneta. Read more...

Global Type 1 Diabetes Treatment Market Value Doubling to $13.6 Billion by 2023

March 19, 2015 9:16 am | by Valentina Gburcik, Ph.D., GlobalData’s Therapy Director of Cardiovascular and Metabolic Disorders | News | Comments

The global treatment market for Type 1 Diabetes (T1D) will expand from $6.6 billion in 2013 to an estimated $13.6 billion by 2023, representing a Compound Annual Growth Rate (CAGR) of 7.6 percent. Read more...

Novartis Gains EU Approval for Rare Blood Cancer Drug

March 19, 2015 9:06 am | News | Comments

This medication is the first targeted treatment approved by the European Commission for these patients. Read more...

AstraZeneca’s COPD Drug: Promising Phase 3 Study

March 18, 2015 1:16 pm | by Stephanie Guzowski, Editor | News | Comments

AstraZenca’s experimental drug, PT003, for chronic obstructive pulmonary disease (COPD) has had successful results in two final-stage Phase 3 trials (24-week studies PINNACLE 1 and PINNACLE 2). Read more...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.